PFM Health Sciences’s Exelixis EXEL Stock Holding History
Bought
Maintained
Sold
Other funds holding EXEL
PFM Health Sciences's EXEL Position: Q3 2026 in Review
PFM Health Sciences opened a new position in Exelixis (EXEL) in Q3 2026: 188,789 shares worth $11M. The stake represents 1.1% of the portfolio and ranks #33 among its holdings.
777 funds tracked by Wall St. Rank hold EXEL as of Q3 2026.
- PFM Health Sciences held 188,789 shares of Exelixis worth $11M as of Q3 2026.
- Exelixis was a new PFM Health Sciences position in Q3 2026.
- Exelixis made up 1.1% of PFM Health Sciences's portfolio in Q3 2026, its #33 holding.
- 777 funds tracked by Wall St. Rank held Exelixis as of Q3 2026.
Based on PFM Health Sciences's 13F filing for Q3 2026, filed 16 Nov 2026.